Yahoo Malaysia Web Search

Search results

  1. Oct 6, 2020 · During an exclusive interview with CBR, Ben 10 showrunner Will Patrick spoke about Ben 10 Versus the Universe: The Movie, the tricky balance between tension and comedy, what really makes Spider-Man and Ben 10 so similar and his favorite part of the franchise.

  2. Oct 7, 2020 · Patrick, who took over showrunner duties from John Fang, was responsible for "keeping the wheels in motion — coordinating people, making sure that everybody was on the same page, that was a lot of what I did," he explains.

  3. Will Patrick is the co-founder and CEO of Culture Biosciences. Will was previously a research assistant at the MIT Media Lab, where they researched digital fabrication and synthetic biology. Their work has been exhibited at the Cooper Hewitt, Smithsonian Design Museum and has been featured in Wired, Fast Company, Dezeen, and Creative Applications.

  4. In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Will Patrick, CEO at Culture Biosciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Will, covering:

  5. Dec 31, 2020 · Will Patrick has spent much of his career thinking about how to build things. During his stints at places like Google[x] where he worked on projects such Project Wing, Google’s drone delivery service, he’d gained an appreciation for the toolsets that helped innovators in the world of hardware and software rapidly innovate and accelerate ...

  6. www.aiche.org › sbe › communityWill Patrick - AIChE

    Will Patrick is the co-founder and CEO of Culture Biosciences. Culture runs a cloud lab for bioreactors. Over 30 synthetic biology and biopharmaceutical companies work with Culture to develop and scale bioprocesses.

  7. Click to read Will Patrick's newsletter, a Substack publication with hundreds of subscribers. I send updates to a few hundred people anytime I've got something worth sharing. New articles, new book notes, new commentary.